Hysteroscopic Septoplasty by Different Modalities

April 6, 2023 updated by: Ahmed Moustafa Alsayed Alamely, Mansoura University Hospital

Hysteroscopic Septoplasty by Different Modalities: A Randomized Clinical Trial

The goal of this clinical trial is to compare in participant population ( women with uterine septum meeting the inclusion criteria) hysteroscopic septoplasty by resectoscope compared to hysteroscopic septoplasty with scissors.

The main questions to answer are:

Is there a difference in operative time ? Is there a difference in fluid used and fluid deficit? Is there a difference in complications? Is there a difference in reproductive outcome? Researchers will compare the 2 different techniques to see if there is any difference in operative outcome ( operative time, fluid used and deficit, need for second intervention, and operative and postoperative complications) and reproductive outcome.

Study Overview

Detailed Description

Study design:

Prospective randomized clinical trial

Study duration and location:

For at least 24 months, Patients admitted to Obstetrics and Gynecology department at Mansoura University Hospital.

Study method

At baseline, the following will be done:

  1. History taking: personal history, menstrual history, obstetrical and gynecological history, present and past history.
  2. Patient presentation (subfertility or pregnancy loss)
  3. Physical examination: General, abdominal and local examination.
  4. Diagnosis of uterine septum either by hysterosalpingogram (HSG), Three dimensional transvaginal ultrasound or office hysteroscopy.

Thereafter:

Patients will be prospectively recruited and randomized by computer program to 2 groups

Group A:

Patients in this group will undergo resection of the septum with hysteroscope and scissors. Saline will be used as a distending medium in the scissors group. Septal incision will be carried out using a thinning technique by which incisions will be made along each side of the septum alternately from one cornual end to the other

Group B:

Patients in this group will undergo resection of the septum with monopolar resectoscope , dilation of cervical os with Hegar's dilators , incision of the septum using a resectoscope with the Collins knife, monopolar energy (cut 50-70 Watt) and glycine 1.5% as the distension medium Sample size calculation Sample size was calculated using Power Analysis and Sample Size software program (PASS) version 15.0.5 for windows (2017) using the results published before with the operative duration of hysteroscopic incision in septate uterus by scissors compared to resectoscope as the primary outcome. The study reported the median operative duration as 10 minutes for resectoscope while that for scissors was 30 minutes. The null hypothesis was considered as the absence of difference between both groups regarding the operative duration. A sample size of 16 patients in each group is needed to achieve 95% power (1-β or the probability of rejecting the null hypothesis when it is false) in the proposed study using a two-sided Fisher exact test with a significance level (α or the probability of rejecting the null hypothesis when it is true) of 5% and hypothesized common standard deviation 15 in both groups. 4 patients drop-out is expected, so a total of 20 patients will be enrolled to each group

Statistical analysis Data will be analyzed using the Statistical Package of Social Science (SPSS) program for Windows (Standard version 24). The normality of data will be first tested with one-sample Kolmogorov-Smirnov test.

Qualitative data will be described using number and percent. Continuous variables will be presented as mean ± standard deviation for normally distributed data and median (IQR) for non-normal data. The following tests will be used; Chi square test: Compare qualitative variables. Fisher exact test and monte carlo test: Compare qualitative variables when expected count less than 5.

Independent t- test: Compare two quantitative variables (parametric). Mann Whitney test: Compare two quantitative variables (Non parametric). For all above mentioned statistical tests , the threshold of significance is fixed at 5% level.The results was considered significant when p ≤ 0.05. The smaller the p-value obtained, the more significant are the results.

Ethical consideration:

  • Study protocol was submitted for approval by Institutional Review Board
  • Approval of the managers of the health care facilities in which the study was conducted.
  • Informed written consent will be obtained from each participant sharing in the study.
  • Confidentiality and personal privacy will be respected in all levels of the study.
  • Collected data will not be used for any other purpose.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dakahlia
      • Mansoura, Dakahlia, Egypt, 35511
        • Faculty of medicine, Mansoura University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Women of reproductive age
  2. Seeking conception
  3. Diagnosis of a septate or subseptate uterus
  4. A history of one of the following:

    • Recurrent pregnancy loss
    • Subfertility
    • Preterm Birth

Exclusion Criteria:

  1. Not seeking conception
  2. Diagnosis of septate or subseptate uterus with no history of any of the following:

    • Recurrent pregnancy loss
    • Subfertility
    • Preterm Birth
  3. Contraindications for surgery
  4. Those who refused to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Scissors arm
Patients in this group had undergone resection of the septum with hysteroscope and scissors, The scissors used was pointed, single action and semi rigid . Saline was used as the distending medium in the scissors group. Septal incision was carried out using shortening technique by incising the septum at the leading edge and continue dividing by moving from side to side (in narrow septum), or by thinning technique by which incisions will be made along each side of the septum alternately from one cornual end to the other (in broad septum). The operation was stopped if the fluid deficit exceeded 2500 ml of saline.
In hysteroscopic septoplasty with scissors arm, incision of the septum was done by continuous flow hysteroscopy and scissors using saline as distension media.
Active Comparator: Resectoscope arm
Patients in this group had undergone resection of the septum with Monopolar 26 French resectoscope Dilation of cervical os with Hegar's dilator (up to hegar 8 or 9) , incision of the septum using a resectoscope with the Collins knife, monopolar energy (cut 40-70 Watt) and glycine 1.5% as the distension medium, using shortening or thinning incision. The operation was stopped if the fluid deficit exceeded 1000 ml of glycine. The delivery of distension media was conducted by automated pressure delivery system. All patients were prescribed cyclic estrogen and progesterone for two months.
In hysteroscopic septoplasty with resectoscope arm, incision of the septum was done by 26 Fr monopolar resectoscope with collin's knife using glycine1.5% as distension media.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Operative time
Time Frame: During surgery
During surgery
Fluid deficit
Time Frame: During surgery
During surgery
Operative and post operative complications
Time Frame: 3 months follow up after intervention
3 months follow up after intervention
Need for second intervention
Time Frame: 3 months follow up after intervention
3 months follow up after intervention

Secondary Outcome Measures

Outcome Measure
Time Frame
Pregnancy rate
Time Frame: At least 6 months follow up after intervention
At least 6 months follow up after intervention
Live birth rate
Time Frame: Follow up until the end of first clinical pregnancy or 6 months after surgery
Follow up until the end of first clinical pregnancy or 6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 16, 2020

Primary Completion (Actual)

March 1, 2023

Study Completion (Actual)

March 21, 2023

Study Registration Dates

First Submitted

March 22, 2023

First Submitted That Met QC Criteria

April 4, 2023

First Posted (Actual)

April 7, 2023

Study Record Updates

Last Update Posted (Actual)

April 10, 2023

Last Update Submitted That Met QC Criteria

April 6, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MD.20.05.324

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recurrent Pregnancy Loss

Clinical Trials on Hysteroscopic septoplasty with scissors

Subscribe